Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease.
Rossato P, Federti E, Matte A, Glantschnig H, Canneva F, Schuster M, Coulibaly S, Schrenk G, Voelkel D, Dockal M, Plaimauer B, Andolfo I, Iolascon A, Rottensteiner H, Gritsch H, Scheiflinger F, Hoellriegl W, Franceschi L.
Rossato P, et al.
Haematologica. 2022 Nov 1;107(11):2650-2660. doi: 10.3324/haematol.2021.280233.
Haematologica. 2022.
PMID: 35443560
Free PMC article.